791137-20-7

Basic information

• Product Name: 5-broMo-2,4-dichloro benzoic acid
• Synonyms: 5-broMo-2,4-dichloro benzoic acid
• CAS NO: 791137-20-7
• Molecular Formula: C₇H₃BrCl₂O₂
• Molecular Weight: 269.90752
• Mol File: 791137-20-7.mol

Chemical Properties

• Melting Point: 187-189 °C
• Boiling Point: 360.8±42.0 °C(Predicted)
• Appearance: /
• Density: 1.900±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 2.23±0.25(Predicted)
• CAS DataBase Reference: 5-broMo-2,4-dichloro benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 5-broMo-2,4-dichloro benzoic acid(791137-20-7)
• EPA Substance Registry System: 5-broMo-2,4-dichloro benzoic acid(791137-20-7)

Safety Data

• Statements: 20/21/22-36/37/38
• Safety Statements: 26-36
• Hazardous Substances Data: 791137-20-7(Hazardous Substances Data)

Usage

Uses

Used in Chemical Synthesis:
5-Bromo-2,4-dichlorobenzoic acid is used as an intermediate in organic synthesis for the production of dyes, perfumes, and pharmaceuticals. Its unique chemical structure allows for the creation of a wide range of compounds with diverse applications.
Used in Agriculture:
In the agricultural industry, 5-bromo-2,4-dichlorobenzoic acid is used as a herbicide and pesticide. It effectively inhibits the growth of certain plants and microorganisms, making it a valuable tool for controlling unwanted vegetation and pests.
Used in Pharmaceutical Development:
Due to its strong acid properties, 5-bromo-2,4-dichlorobenzoic acid is utilized in the development of pharmaceuticals. It can be incorporated into the synthesis of various drugs, potentially leading to new treatments and therapies for a range of medical conditions.

Upstream product

• 7790-94-5 chlorosulfonic acid 
• 50-84-0 2,4 dichlorobenzoic acid 
• 7726-95-6 bromine 

Downstream Products

• 1305712-91-7 methyl 5-bromo-2,4-dichlorobenzoic acid 
• 1313513-27-7 (2S,3R,4R,5S,6R)-2-(2,4-dichloro-5-((5-(thiophen-3-yl)thiazol-2-yl)methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol 
• 1313513-26-6 (2S,3R,4R,5S,6R)-2-(2,4-dichloro-5-((5-(thiophen-2-yl)thiazol-2-yl)methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol 
• 1313513-25-5 (2S,3R,4R,5S,6R)-2-(2,4-dichloro-5-((5-(furan-3-yl)thiazol-2-yl)methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol 
• 1313513-24-4 (2S,3R,4R,5S,6R)-2-(2,4-dichloro-5-((5-(furan-2-yl)thiazol-2-yl)methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol 
• 1259020-42-2 2-(2,4-dichloro-5-((2S,3S,4R,5R,6R)-3,4,5-tris(benzyloxy)-6-(benzyloxymethyl)-tetrahydro-2H-pyran-2-yl)phenyl)acetic acid 
• 1259020-38-6 (5-bromo-2,4-dichlorobenzyloxy)triisopropylsilane 

Relevant articles and documents

PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same.

Thiazolylmethyl ortho-substituted phenyl glucoside library as novel C-aryl glucoside SGLT2 inhibitors

In order to investigate SAR regarding proximal phenyl ring in novel C-aryl glucoside SGLT2 inhibitors containing a thiazole motif, a series of chemical modifications on proximal phenyl ring was conducted. During a series of lead optimization efforts, orth

NOVEL C-ARYL GLUCOSIDE SGLT2 INHIBITORS AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

A novel C-aryl glucoside compound, or a pharmaceutically acceptable salt or a prodrug thereof having an inhibitory activity against sodium-dependent glucose cotransporter 2 (SGLT2) being present in the intestine and kidney; and a pharmaceutical composition comprising the same as an active ingredient, which is useful for preventing or treating metabolic disorders, particularly, diabetes, are provided.

An improved synthesis of 1-acetyl-1H-indol-3-yl acetates

(Chemical Equation Presented) An efficient two steps procedure for the synthesis of 1-acetyl-1H-indol-3-yl acetates, starting from 2-chlorobenzoic acids, was developed and in general, moderate to good yields were obtained.